Patent · US Active

Aptamer against midkine and applications thereof

US9506070B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 21, 2013
Grant dateNov 29, 2016
Priority date
Expiry dateNov 21, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides an aptamer binding to midkine and capable of forming a potential secondary structure represented by the formula (I):whereinX1, X2, X5 and X6 are the same or different and each is one or two nucleotides selected from the group consisting of A, G, C, U and T, or a bond,X1 and X6, and X2 and X5 each form a Watson-Crick base pairs, andX3 and X4 are the same or different and each is a nucleotide selected from A, G, C, U and T.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.